Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented ...

Palm Beach, FL – March 10, 2025 – A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...

Aclarion, Inc. (NASDAQ:ACON) experienced a dramatic decrease of 74.13% in its stock price. Elevai Labs, Inc. (ELAB) saw a substantial price drop of 42.63%. Sleep Number Corporation (SNBR) reported a ...

Experienced executive to lead global operations and strategic partnerships in drive to commercialize semiconductor technology MANCHESTER, England, March 10, 2025 /PRNewswire/ -- Smartkem ...